Foto: Nykredit/Presse Han påpeger eksempelvis ... Ifølge cheføkonomen kan store danske virksomheder som Novo Nordisk eller Lego stå for skud, hvis Trump forsøger at målrette sine toldangreb.

Uden fondene risikerer vi, at borgernes behov og det politiske systems beslutninger glider fra hinanden. Fondene spiller en vigtig rolle ved at mobilisere borgere og bygge bro mellem civilsamfund, bor ...

However, Novo Nordisk (NYSE: NVO), a pioneer in the field, remains one of the leaders. That likely won't change anytime soon, since the Denmark-based pharmaceutical giant has an excellent pipeline.

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...

Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But there’s still a long way to go to claw back the declines of the past ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, also known as semaglutide, has been approved to reduce the risk of kidney disease worsening, kidney failure, and death from ...

Den danske medicinalgigant Novo Nordisk har indgået et forlig i en langstrakt sag fra 2018 i den amerikanske delstat ...

Finally, some good news for Novo Nordisk (NYSE: NVO) shareholders! Twice in the past two months, the Danish manufacturer of GLP-1 drugs for weight loss and diabetes treatment has reported clinical ...

LONDON, Jan 30 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab will begin a late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10 to test its long-term efficacy ...